Itama Ranoraya PT

Itama Ranoraya PT Equity

The The Equity of Itama Ranoraya PT (IRRA.JK) as of Oct 17, 2026 is 577.83 B IDR. In the previous year, The Equity was 512.31 B IDR — a change of 12.79% (higher).

Equity

577.83 BIDR

YoY

12.79%

Last updated:

In 2025, Itama Ranoraya PT's equity was 577.83 B IDR, a 12.79% increase from the 512.31 B IDR equity in the previous year.

The Itama Ranoraya PT Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
66.64 B IDR
Jan 1, 2019
235.17 B IDR
Jan 1, 2020
242.33 B IDR
Jan 1, 2021
502.05 B IDR
Jan 1, 2022
484.04 B IDR
Jan 1, 2023
459.20 B IDR
Jan 1, 2024
512.31 B IDR
Jan 1, 2025
577.83 B IDR
The Itama Ranoraya PT Equity history
YEAREquityYoY
577.83 BIDR+12.79%
512.31 BIDR+11.57%
459.20 BIDR-5.13%
484.04 BIDR-3.59%
502.05 BIDR+107.18%
242.33 BIDR+3.05%
235.17 BIDR+252.88%
66.64 BIDR+50.27%
44.35 BIDR+311.36%
10.78 BIDR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Itama Ranoraya PT Stock analysis

What does Itama Ranoraya PT do? Itama Ranoraya PT, trading as IRRA.JK, is a medical devices distributor headquartered in Jakarta Timur, Indonesia. The company employs 209 full-time staff and went public on October 15, 2019. It operates in the wholesale trade of laboratory equipment, pharmaceutical equipment, and human medical devices. Its product segments include non-electromedical sterile medical devices, in-vitro diagnostics, electromedical sterile medical devices, and other products. Key business areas cover in-vitro diagnostics, medical imaging, surgical instruments, critical care, blood banking, cardiovascular care, neurology, oncology, urology, and maternal and neonatal care. Product brands include Oneject, Abbott, Terumo, Becton Dickinson, HMD, Vestfrost, Balmed, iGene, AVIMAC, and HemoCue. Itama Ranoraya PT is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Itama Ranoraya PT's Equity

Itama Ranoraya PT's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Itama Ranoraya PT's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Itama Ranoraya PT's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Itama Ranoraya PT's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Itama Ranoraya PT’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Itama Ranoraya PT stock

The Equity of Itama Ranoraya PT is 577.83 B IDR in 2025.

The Equity of Itama Ranoraya PT changed from 512.31 B IDR to 577.83 B IDR, representing a 12.79% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Itama Ranoraya PT since 2006 – with annual values, charts, and detailed analysis.

The Equity's IDR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Itama Ranoraya PT historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Itama Ranoraya PT

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Itama Ranoraya PT